Lung Cancer Considered

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao, Dr. Mong-Wei Lin, and Dr. Po-Lan Su, leading lung cancer experts in Taiwan, who share their perspectives on key highlights from the conference.

Guests:
Kuan-Yu Chen, MD, PhD
Clinical Professor and Chief, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
National Taiwan University Hospital and College of Medicine

Bin-Chi Liao, MD
Department of Medical Oncology
National Taiwan University Cancer Center

Mong-Wei Lin, MD, PhD
Professor of Surgery, National Taiwan University College of Medicine
Chief, Division of Thoracic Surgery
National Taiwan University Hospital

Dr. Po-Lan Su, MD, PhD
Clinical Associate Professor, Department of Internal Medicine
National Chung Kung University Hospital, Taiwan

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, host Dr. Ory Wiesel moderates a discussion in Hebrew with Dr. Jair Bar, Dr. Nir Peled, and Dr. Hadas Sorotsky about highlights from the conference.

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers.

Dr. Sara Fra, Dr. Cassio Murilo Hidalgo Filho, and Dr. Nan Sethakorn discuss the research presented at the meeting, the value of bringing together a multidisciplinary and international community, and the networking opportunities that helped them connect with colleagues across specialties.

They reflect on their experiences in the IASLC Academy and highlight specific career development opportunities including mentorship, grants, research support, and the Early Career Forum.

Guests:
Sara Fra, MD
Thoracic Surgeon
Department of Thoracic Surgery
Ramón y Cajal University Hospital

Cassio Murilo Hidalgo Filho, MD
Medical Oncology, Postdoctoral Fellow
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute
Harvard Medical School

Nan Sethakorn, MD, PhD
Thoracic Oncologist
Basic Translational Researcher
Loyola University Chicago

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul.

In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan.

Guests:
Nagla Karim, MD
Professor of Medicine
Director of Thoracic Oncology and Phase I Programs
George Washington University

Hesham Elghazaly, MD
Professor of Clinical Oncology
Ain Shams University

Arafat Tfayli, MD
Chief of Hematology/Oncology and Professor of Clinical Medicine
American University of Beirut Medical Center

Bashir Abu Aqeel, MD
Medical Oncologist
Augusta Victoria Hospital

Riad Abdel Jalil, MD
Thoracic Surgeon
King Hussein Cancer Center

Adda Bounedjar, MD
Professor of Medical Oncology
Blida 1 University

Rasha Aboelhassan, MD
Senior Oncology Consultant
Nasser Institute for Research and Treatment

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park.

Guests:

Ji-Youn Han, MD, PhD
Professor
National Cancer Center of Korea
X: @oncologyhan

Tae Min Kim, MD, PhD
Professor
Seoul National University Hospital
No Social

Sehhoon Park, MD, PhD
Division of Hematology-Oncology, Department of Medicine
Samsung Medical Center, Sungkyunkwan University School of Medicine
LinkedIn: https://www.linkedin.com/in/sehhoon-park/